COMMUNIQUÉS West-GlobeNewswire

Easy Environmental Solutions Participates in International Roundtable at United Nations Headquarters During Climate Week NYC
24/09/2026
Company advances international relationships around localized fertilizer production, agricultural resilience, and commercial infrastructure development MANKATO, Minn. and NEW YORK, Sept. 24, 2026 (GLOBE NEWSWIRE) -- [...]
CORRECTION – Free Family Fun Night in Cedar Park: Ally Medical ER Ribbon Cutting
24/09/2026
Ally Medical ER Cedar Park hosts an evening of free food, drinks, giveaways, and kid-friendly games on October 1st. CEDAR PARK, Texas, Sept. 24, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline [...]
Eurobio Scientific: Results for the first semester of fiscal year 2026
24/09/2026
RESULTS FOR THE FIRST SEMESTER OF FISCAL YEAR 2026 Revenue up 4.5% to 84.5 M€ Proprietary products account for 37% of revenue 46% of revenue generated outside France Free cash flow of €4 million after investments Net [...]
Eurobio Scientific: Résultat du 1er semestre 2026
24/09/2026
RESULTAT DU 1 ER SEMESTRE 2026 Chiffre d’affaires en croissance de 4,5% à 84,5 M€ les produits propriétaires atteignent 37% du CA la part du CA hors France est de 46% Flux de trésorerie disponible de 4 M€ après [...]
SK pharmteco lance un kit de catalyseurs destiné à rationaliser le développement des réactions catalytiques et leur mise à l’échelle en fabrication continue
24/09/2026
Cette nouvelle offre structurée vise à assurer la continuité entre le criblage des catalyseurs, l’optimisation des procédés et la fabrication en flux continu à l’échelle commerciale pour les matières premières [...]
SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)
24/09/2026
SRX has added ONCO in anticipation of Realbotix LLC acquisition closing. Believes Vinci AI Vision system is extremely undervalued and misunderstood, with multiple potential applications in defense, ranging from drones [...]
Cullinan Therapeutics Highlights Fourth Quarter 2026 Milestones Across Immunology and Oncology T Cell Engager Portfolio
24/09/2026
Velinotamig (BCMA TCE) multi-dose regimen data in SLE at ACR Convergence 2026 in November CLN-978 (CD19 TCE) multi-dose regimen data in SLE, RA and Sjögren’s disease in December CLN-049 (FLT3 TCE) updated data from the [...]
Satellos Announces FDA Clearance of IND Application for Forazapadin in Facioscapulohumeral Muscular Dystrophy (FSHD) and a Partnership with FSHD Canada Foundation Providing Non-Dilutive Financing to Support Clinical Development
24/09/2026
FDA clearance expands development of forazapadin into a second degenerative muscle disease with significant unmet medical need FSHD Canada Foundation to provide up to US$5 million in non-dilutive financing toward the [...]
Atavistik Bio Announces Strategic Research Collaboration with Roche to Discover and Develop Novel Allosteric Therapeutics
24/09/2026
Collaboration leverages Atavistik Bio’s proprietary AMPS TM platform to identify and advance novel allosteric small molecules against multiple targets for cardiometabolic diseases Atavistik Bio to receive $70 million [...]
What CX Leaders Should Understand About Customer Support Outsourcing
24/09/2026
Transcom supports more than 300 clients globally, including disruptive e-commerce players and category-redefining fintechs, across 29 countries. Transcom's autopilot conversational AI bots resolve high-volume contacts [...]
Medicenna Announces Oral Presentation of New Bizaxofusp Results in Recurrent Glioblastoma at the 2026 Society for Neuro-Oncology Annual Meeting
24/09/2026
TORONTO and HOUSTON, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company developing Superkines for targeting [...]
Coave Therapeutics to Present New Data on Wet AMD Gene Therapy Program at 26th Euretina Congress as it Advances towards the Clinic
24/09/2026
Dr. Nora Dimon, VP of Clinical Development, to present preclinical findings on the Company’s lead retinal program, CoTx-101, including non-human primate data Rodolphe Clerval, CEO, to deliver a corporate presentation at [...]
Kraig Biocraft Laboratories Reaches Major Scientific Milestone with Completion of Functional and Living Atlas Gene Library
24/09/2026
ANN ARBOR, Mich., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced a major [...]
Profusa Announces Significant Progress Towards Lumee® Oxygen Platform CE Mark with ISO 13485 Certification Expected in Early October
24/09/2026
BERKELEY, CA, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA), a digital health company pioneering next-generation biosensor technologies today announced that the Company has received a positive decision [...]
Kala Bio and Virotek Sign Letter of Intent with U.S. DNA Testing Platform to Resell Virotek's Suite of Genetic Testing Products
24/09/2026
Agreement would expand the companies' genetic testing collaboration beyond ophthalmology to a selected suite of genomic testing products through an additional U.S. reseller channel ARLINGTON, Mass., Sept. 24, 2026 ( [...]
Immuneering to Present at the ESMO Congress 2026
24/09/2026
- Trial in progress poster will highlight the ongoing Phase 3 MAPKeeper 301 trial of atebimetinib + mGnP in first-line pancreatic cancer patients - NEW YORK, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation ( [...]
Sofwave Receives NMPA Approval in Mainland China
24/09/2026
NMPA approval supported by a 200-subject, randomized, controlled study in China demonstrating statistically significant improvement in mid-to-lower facial wrinkles and a favorable safety profile China represents a [...]
Annexon to Present Patient Baseline Characteristics from Vonaprument Phase 3 ARCHER II Pivotal Trial for Geographic Atrophy at The Retina Society 59th Annual Scientific Meeting
24/09/2026
Oral Presentations Highlight Phase 2 Vision Protection and Enrollment of a Consistent Phase 3 Patient Population Well-Positioned to Replicate Phase 2 Vision Outcomes ARCHER II is the First Pivotal Trial Designed to [...]
New Preclinical Data Further Support Potential for Tvardi’s STAT3 Inhibitors in Ulcerative Colitis (UC)
24/09/2026
In a preclinical chronic colitis model, Tvardi’s oral small molecule accumulated in the colon at approximately 8-fold higher concentrations than in plasma, at pharmacologically relevant levels, and modulated STAT3- [...]

Pages